A Stat survey of nearly 1,000 NIH grantees shows 27% got no funding back after a $32 billion cut, while only 35% saw full restoration. Experts warn the loss slowed careers, pushed talent to industry or abroad, and could undercut future breakthroughs and public health.

This article explains how healthcare organizations can get a HIPAA-compliant Business Associate Agreement with OpenAI to process protected health information via the API. Email baa@openai.com with your company details and use case; most requests are approved within a few business days. If your request is denied, you can seek reconsideration through your sales contact.

Pete McCanna argues that most health systems are built to fill capacity instead of creating value for patients and is overhauling Baylor Scott & White around “customers” rather than “patients.” He outlines how loyalty-driven, sometimes loss-leading services, AI-powered differentiation, and rewritten healthcare laws fit into a model that prioritizes access, personalization, and long-term trust over short-term profit.

This article profiles eight healthcare services companies using AI across their care stacks to cut costs, speed up treatment, and boost patient engagement. From smarter caregiver scheduling at Honor to AI-driven patient outreach at Cityblock, each example shows measurable improvements in outcomes, efficiency, or retention. The piece argues that service-focused models with embedded AI have a durable edge over pure software plays.

Prompt Opinion lets healthcare organizations plug in interoperable AI agents, tools, and standards into real workflows. It uses MCP, A2A, and FHIR to connect EHRs, policies, and data, turning standalone agents into production-ready tasks like prior authorizations, trial matching, and population health analyses.

Americans spend more on healthcare than any other country, largely because the U.S. pays far higher prices for the same surgeries, drugs and medical services. Increased use of costly hospital care and new weight-loss medications has driven spending even higher.

Shiv Rao, cardiologist-turned-CEO of Abridge, explains why the company focuses on doctor-patient conversations rather than just notes, how it builds 70–80% of its own AI models, and why it retains full control despite raising $800 million. He also outlines Abridge’s edge over dozens of rival scribes, its new real-time prior-auth tool, and how it navigates liability and regulation.

Sutter Health and Allina Health have signed a Letter of Intent for Allina Health to join Sutter, creating a combined nonprofit health system. This partnership aims to enhance patient access, affordability, and care quality through technological advancements and expanded services in Minnesota and western Wisconsin.

Mark Cuban discusses his approach to fixing healthcare, emphasizing transparency in drug pricing and the need to dismantle the influence of pharmacy benefit managers. He advocates for cash pricing legislation and supports the Break Up Big Medicine Act to separate insurance companies from their non-insurance interests.

The article discusses the Centers for Medicare & Medicaid Services (CMS) efforts to transition healthcare providers and insurers away from outdated, manual methods of sharing patient information. This initiative aims to streamline data exchange and improve efficiency within the healthcare system.

This article highlights the legal risks of Pharmacy Benefit Manager (PBM) contracts for employers due to new fiduciary duties. It introduces RootTrust, a platform that analyzes these contracts, providing clarity and compliance to protect companies from financial and legal pitfalls.

The FDA plans to reduce the number of required pivotal trials in Phase 3 clinical studies from two to one, aiming to streamline drug development. While this may benefit smaller biotech companies, the impact will vary by disease, as some conditions may still necessitate more trials to ensure safety and efficacy.

The FDA plans to allow drug approvals based on a single clinical trial instead of the traditional two. Commissioner Marty Makary stated that this change aims to streamline the approval process while maintaining safety and efficacy standards. Some exceptions will still apply, where two trials may be required.

Hospital-at-home care is facing significant challenges in managing medical waste, as existing disposal regulations do not fully apply to at-home settings. Healthcare professionals report difficulties with proper waste management, which raises safety concerns for patients and caregivers. As the model continues to grow, there is a pressing need for proactive regulation and effective waste disposal solutions.

The article discusses the importance of data activation in enhancing the performance of large language models (LLMs), particularly in the healthcare sector. It highlights recent advancements in transforming structured medical data into usable formats for LLMs, emphasizing the need for effective reasoning methods to fully leverage the potential of healthcare data.

The article provides official guidance on how the Health Insurance Portability and Accountability Act (HIPAA) applies to online tracking technologies. It emphasizes the importance of protecting patient privacy and ensuring compliance when using digital tools for tracking purposes. The content is aimed at professionals navigating these regulations.

Claude for Healthcare is now available, providing HIPAA-compliant tools for healthcare providers and patients to improve medical processes such as prior authorizations and claims appeals. Additionally, Claude for Life Sciences has expanded its capabilities to better support clinical trial operations and regulatory submissions. These advancements aim to streamline healthcare tasks and enhance the quality of patient care.

Many users are unaware that conversations with consumer AI about health issues lack legal protections, unlike communications with licensed healthcare providers. This article highlights the risks of disclosing personal health information to AI, which can be subpoenaed in legal situations, exposing users to potential misuse of their private data. It emphasizes the importance of understanding what privileges are lost when opting for AI assistance over traditional healthcare communications.

ChatGPT Health may be a marketing strategy rather than a genuine innovation, potentially allowing tech giants to dominate the healthcare sector. The article questions OpenAI's claims of enhanced security and adherence to HIPAA standards, drawing parallels to past controversies with data privacy in the tech industry.

Multimodal vector databases like ApertureDB are revolutionizing how industries manage and verify data, particularly in healthcare advertising. By integrating various data types and employing AI tools, these databases enhance compliance by detecting omissions in marketing content, ensuring that critical information is accurately conveyed to patients.

Mark Cuban and Optum CEO Patrick Conway engaged in a heated discussion about drug prices and pharmacy benefit managers, highlighting their differing views on how to reform the healthcare system. Cuban argued for breaking up large insurance companies and criticized the lack of transparency in PBM contracts, while Conway emphasized the need to tackle high hospital and pharmaceutical costs. Both acknowledged the other's contributions but remained divided on the root causes of high drug prices and solutions.

The article discusses the challenges and stagnation in healthcare AI, highlighting that the industry is significantly behind other sectors despite advancements in technology. It also emphasizes the need for transparency and innovation in healthcare, mentioning ongoing investigations into unethical practices by certain organizations.

TrumpRx, a new public-private program launched by the Trump administration in partnership with Pfizer, aims to offer direct-to-consumer drug sales at significantly reduced prices. While it seeks to provide discounts on medications, experts suggest it closely resembles existing DTC models like Cost Plus Drugs and may not substantially impact the majority of patients who rely on insurance for prescriptions.

ClearCare Online's API documentation outlines the importance of digital data sharing in healthcare, detailing various data types, including simple and complex types, as well as the authentication flow using OAuth 2.0. It also highlights enhancements and bug fixes in recent releases to improve data management and compliance with FHIR standards.